✦ LIBER ✦

Hyperkalemic periodic paralysis with cardiac dysrhythmia: A novel sodium channel mutation?

✍ Scribed by Jaime L. Baquero; Ricardo A. Ayala; Jianzhou Wang; Dr. Richard G. Curless; W. Gregory Feero; Eric P. Hoffman; Makram R. Ebeid

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 449 KB
Volume: 37
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410370320

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A proposed mutation, Val781Ile, associat

A proposed mutation, Val781Ile, associated with hyperkalemic periodic paralysis and cardiac dysrhythmia is a benign polymorphism

✍ Donnella S. Green; Lawrence J. Hayward; Alfred L. George Jr.; Stephen C. Cannon 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB

Paramyotonia congenita and hyperkalemic

Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene

✍ Dr. G. C. Ebers; A. L. George; R. L. Barchi; S. S. Ting-Passador; R. G. Kallen; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB

Linkage of malignant hyperthermia and hy

Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel (SCN4A) gene in a large pedigree

✍ Moslehi, Roxana; Langlois, Sylvie; Yam, Irene; Friedman, J.M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

Hyperkalemic periodic paralysis (HPP) is caused by mutations of the adult skeletal muscle sodium channel (SCN4A) gene on chromosome 17. Malignant hyperthermia (MH) is a genetically heterogeneous autosomal-dominant disorder occurring in association with various neuromuscular diseases or without other

A Novel mutation L619F in the cardiac Na

A Novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating

✍ Xander H.T. Wehrens; Tom Rossenbacker; Roselie J. Jongbloed; Marc Gewillig; Hein 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB

Congenital long QT syndrome type 3 (LQT3) is caused by mutations in the gene SCN5A encoding the alpha-subunit of the cardiac Na(+) channel (Nav1.5). Functional studies of SCN5A mutations in the linker between domains III and IV, and more recently the C-terminus, have been shown to alter inactivation